Biohaven (BHVN) Shares Outstanding (Diluted Average) (2021 - 2026)

Biohaven has disclosed Shares Outstanding (Diluted Average) across 6 years of filings, most recently posting $147.6 million for Q1 2026.

• Shares Outstanding (Diluted Average) for Q1 2026 came in at $147.6 million, up 44.8% year-over-year; the trailing twelve-month figure through Mar 2026 was $147.6 million (up 44.8% YoY), and the FY2025 annual result was $107.6 million, up 17.97% from the prior year.
• Shares Outstanding (Diluted Average) came in at $147.6 million for Q1 2026 at Biohaven, up from $107.6 million in the prior quarter.
• In the past five years, Shares Outstanding (Diluted Average) ranged from a high of $147.6 million in Q1 2026 to a low of $39.4 million in Q1 2022.
• The 5-year median for Shares Outstanding (Diluted Average) is $81.6 million (2024), against an average of $79.8 million.
• Across the five-year window, Shares Outstanding (Diluted Average) climbed 0.02% in 2022 and jumped 73.35% in 2023, its largest moves.
• Biohaven's Shares Outstanding (Diluted Average) stood at $44.7 million in 2022, then surged by 59.14% to $71.2 million in 2023, then grew by 28.14% to $91.2 million in 2024, then advanced by 17.97% to $107.6 million in 2025, then jumped by 37.16% to $147.6 million in 2026.
• The last three Shares Outstanding (Diluted Average) figures came in at $147.6 million (Q1 2026), $107.6 million (Q4 2025), and $103.4 million (Q3 2025), per Business Quant data.